0.13Open0.13Pre Close3 Volume955 Open Interest65.00Strike Price39.00Turnover91.24%IV15.16%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.13Extrinsic Value100Contract SizeAmericanOptions Type-0.0417Delta0.0120Gamma588.15Leverage Ratio-0.0699Theta-0.0004Rho-24.53Eff Leverage0.0072Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet